The average user in the early testing for Novo's drug is insane. They're from market cap as double in the past year on the strength of this drug. But like Jack said, it's like, if you can just do once a month injections now and they're working on a pill, yeah, you have this might just go to complete shit,. That is more than me. I want to try to call myself media delivery person when I was that.
The NIA boys discuss the “miracle” obesity drug, Chris Rock’s new Netflix Special, Balaji's book, living a healthy lifestyle, and much more.
Timestamps:
- (00:00:00) Intro
- (00:01:13) Meme of the Week
- (00:03:12) Chris Rock’s new Netflix Special
- (00:06:22) Debating Netflix's Binge Drop Model
- (00:08:45) Jack’s White Lotus Review
- (00:10:39) The best way to consume stand up comedy
- (00:12:59) The Anthology of Balaji | Exclusive Sneak Peek
- (00:18:13) Breakdown of Ozempic, The Obesity Drug
- (00:19:43) How drugs find new use cases
- (00:22:54) Debate over Ozempic being used as a Lifestyle Drug
- (00:24:08) The Economics of Obesity Drugs
- (00:25:59) How effective are drugs like Ozempic?
- (00:27:18) Illustrating the Complexity of the Obesity Epidemic
- (00:33:13) Healthy Eating
- (00:36:46) Jacked Jack
- (00:37:47) Quality of US Food vs European Food
- (00:39:19) Portion Sizing is Frustrating
- (00:42:26) Holistic Approach to a Healthy Lifestyle
- (00:44:44) The Economic Inequality of Eating Healthy
- (00:46:40) The Benefits of Being Young
- (00:48:08) Wrapping up the Obesity Drug Discussion
- (00:51:43) Defining “Healthy” is Relative
- (00:53:34) Final Thoughts
What Is Not Investment Advice? Every week, Jack Butcher, Bilal Zaidi & Trung Phan discuss what they're finding on the edges of the internet + the latest in business, technology and memes.
Watch + Subscribe on Youtube:
https://youtu.be/fYcLWO26fds
Listen into our group chat on Telegram:
https://t.me/notinvestmentadvice
Let us know what you think on Twitter:
@bzaidi
@trungtphan
@jackbutcher
@niapodcast
Links Mentioned:
Hosted on Acast. See acast.com/privacy for more information.